Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease
- PMID: 10022341
Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease
Abstract
Two types of dystrophic neurites have been described in neuritic plaques in Alzheimer's disease (AD). Type 1 dystrophic neurites display tau-positive paired helical filaments (PHF) while those of type 2 are swollen and positive for both amyloid precursor protein and Chromogranin A. To determine the role of these two types of dystrophic neurites in the development of neuritic plaques, we examined their distribution in CA 1, CA 4, the entorhinal and the temporal cortex throughout all Braak-stages. Fourty cases with AD-related neurofibrillary changes were evaluated semi-quantitatively. The frequency of neuritic plaques displaying both types of dystrophic neurites seemed to increase from stage I to stage IV and to remain stable or slightly decrease in later stages. Staining combinations detecting type 1 (Gallyas, immunohistochemistry against hyperphosphorylated tau-protein) and type 2 dystrophic neurites simultaneously (immunohistochemistry against the amyloid precursor protein or Chromogranin A) showed coexpression of the type 1 and type 2 pattern in single neurites of neuritic plaques. In the entorhinal and temporal cortex, occasional neuritic plaques displayed tau-immunopositive changes in the absence of swollen type 2 neurites. Since amyloid precursor protein is expressed in distal ends of neurites after various brain lesions we suggest that amyloid precursor protein-positive neurites in neuritic plaques indicate dysfunctional axonal transport due to type 1 neurofibrillary changes.
Similar articles
-
Pathogenesis of Alzheimer-related neuritic plaques: AT8 immunoreactive dystrophic neurites precede argyrophilic neurites in plaques of the entorhinal region, hippocampal formation, and amygdala.Clin Neuropathol. 1998 Jul-Aug;17(4):194-8. Clin Neuropathol. 1998. PMID: 9707333
-
Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.J Comp Neurol. 1993 Aug 8;334(2):176-91. doi: 10.1002/cne.903340203. J Comp Neurol. 1993. PMID: 7690048
-
Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.Acta Neuropathol. 2004 Nov;108(5):435-42. doi: 10.1007/s00401-004-0907-2. Epub 2004 Sep 14. Acta Neuropathol. 2004. PMID: 15372280
-
Truncated tau protein as a new marker for Alzheimer's disease.Acta Virol. 1994 Jun;38(3):173-89. Acta Virol. 1994. PMID: 7817900 Review.
-
Alteration of neuritic cytoarchitecture in Alzheimer disease.Prog Clin Biol Res. 1989;317:781-9. Prog Clin Biol Res. 1989. PMID: 2690122 Review.
Cited by
-
Early Dendritic Dystrophy in Human Brains With Primary Age-Related Tauopathy.Front Aging Neurosci. 2020 Dec 7;12:596894. doi: 10.3389/fnagi.2020.596894. eCollection 2020. Front Aging Neurosci. 2020. PMID: 33364934 Free PMC article.
-
Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.Acta Neuropathol Commun. 2019 Nov 14;7(1):178. doi: 10.1186/s40478-019-0837-9. Acta Neuropathol Commun. 2019. PMID: 31727169 Free PMC article. Clinical Trial.
-
β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.Eur J Neurosci. 2010 Oct;32(7):1223-38. doi: 10.1111/j.1460-9568.2010.07376.x. Epub 2010 Aug 18. Eur J Neurosci. 2010. PMID: 20726888 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials